Company logo

RPTX - Repare Therapeutics Inc.

NASDAQ -> Healthcare -> Biotechnology
Montreal, Canada
Type: Equity

RPTX price evolution
RPTX
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $111.27 $107.37 $115.54 $121.46
Short term investments $112.36 $142.7 $165.15 $192.66
Net receivables $4.5 $3.73 $5.28 $5.35
Inventory
Total current assets $243.69 $275.09 $291.93 $325.53
Long term investments
Property, plant & equipment $7.54 $8.61 $9.26 $10.37
Goodwill & intangible assets
Total noncurrent assets $10.21 $11.31 $9.66 $10.78
Total investments $112.36 $142.7 $165.15 $192.66
Total assets $253.9 $286.41 $301.59 $336.31
Current liabilities
Accounts payable $2.4 $5.44 $4.89 $3.62
Deferred revenue $11.95 $22.95 $25.11 $54.11
Short long term debt $2.4 $2.33 $2.32 $2.26
Total current liabilities $39.08 $48.97 $53.25 $80.94
Long term debt $1.01 $1.59 $2.23 $2.78
Total noncurrent liabilities $2.74 $4.07 $2.92 $4.13
Total debt $3.41 $3.92 $4.55 $5.04
Total liabilities $41.82 $53.04 $56.17 $85.06
Shareholders' equity
Retained earnings -$333.11 -$305.08 -$286.2 -$274.25
Other shareholder equity $0.03 -$0.25 -$0.42 -$0.23
Total shareholder equity $212.08 $233.37 $245.41 $251.24
(in millions $) 31 Jan 2024 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $111.27 $159.52 $334.43 $326.4
Short term investments $112.36 $184.42 $7.44 $7.53
Net receivables $4.5 $4.32 $0.65 $4.15
Inventory
Total current assets $243.69 $353.98 $351.41 $346.55
Long term investments
Property, plant & equipment $7.54 $9.6 $13.1 $8.62
Goodwill & intangible assets
Total noncurrent assets $10.21 $10.1 $17.3 $10.53
Total investments $112.36 $184.42 $7.44 $7.53
Total assets $253.9 $364.07 $368.71 $357.09
Current liabilities
Accounts payable $2.4 $0.46 $2.3 $2.25
Deferred revenue $11.95 $55.78 $51.53 $58.01
Short long term debt $2.4 $2.17 $1.72 $0.7
Total current liabilities $39.08 $78.62 $35.09 $11.01
Long term debt $1.01 $3.26 $5.59 $3.31
Total noncurrent liabilities $2.74 $5.94 $45.2 $59.24
Total debt $3.41 $5.43 $7.31 $4
Total liabilities $41.82 $84.56 $80.29 $70.26
Shareholders' equity
Retained earnings -$333.11 -$239.31 -$210.27 -$103.36
Other shareholder equity $0.03 -$0.43
Total shareholder equity $212.08 $279.52 $288.42 $286.83
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $13.05 $2.16 $30.25 $5.68
Cost of revenue
Gross Profit $13.05 $2.16 $30.25 $5.68
Operating activities
Research & development $35.27 $32.71 $33.79 $31.83
Selling, general & administrative $8.65 $7.87 $8.72 $8.53
Total operating expenses $43.91 $40.58 $42.51 $40.36
Operating income -$30.87 -$38.42 -$12.26 -$34.68
Income from continuing operations
EBIT -$27.84 -$35.18 -$8.84 -$31.32
Income tax expense $0.19 -$16.3 $3.11 $3.62
Interest expense
Net income
Net income -$28.03 -$18.88 -$11.95 -$34.94
Income (for common shares) -$28.03 -$18.88 -$11.95 -$34.94
(in millions $) 31 Jan 2024 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $131.83 $7.6 $0.14
Cost of revenue
Gross Profit $131.83 $7.6 $0.14
Operating activities
Research & development $119.07 $90.05 $40.09
Selling, general & administrative $32.56 $26.21 $14.35
Total operating expenses $151.63 $116.26 $54.44
Operating income -$19.8 -$108.66 -$54.3
Income from continuing operations
EBIT -$13.9 -$108.59 -$54.74
Income tax expense $15.15 -$1.68 -$1.32
Interest expense
Net income
Net income -$29.05 -$106.91 -$53.42
Income (for common shares) -$29.05 -$106.91 -$53.42
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$28.03 -$18.88 -$11.95 -$34.94
Operating activities
Depreciation $1.06 $1.05 $1.05 $0.98
Business acquisitions & disposals
Stock-based compensation $6.36 $6.38 $6.26 $6.06
Total cash flows from operations -$28.16 -$32.87 -$34.35 -$31.79
Investing activities
Capital expenditures -$0.4 -$1.06 -$0.47
Investments $32.28 $24.5 $29.41 -$6.21
Total cash flows from investing $31.88 $24.5 $28.35 -$6.69
Financing activities
Dividends paid
Sale and purchase of stock $0.1 $0.28 $0.04 $0.41
Net borrowings
Total cash flows from financing $0.1 $0.28 $0.04 $0.41
Effect of exchange rate $0.07 -$0.09 $0.04 -$0
Change in cash and equivalents $3.9 -$8.18 -$5.92 -$38.06
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$93.8 -$29.05 -$106.91 -$53.42
Operating activities
Depreciation $4.14 $4.18 $3.34 $1.79
Business acquisitions & disposals
Stock-based compensation $25.06 $19.69 $12.83 $2.54
Total cash flows from operations -$127.16 $0.32 -$85.8 -$6.08
Investing activities
Capital expenditures -$1.94 -$0.6 -$1.65 -$2.24
Investments $79.98 -$175.18 -$0.03 -$7.53
Total cash flows from investing $78.04 -$175.78 -$1.68 -$9.76
Financing activities
Dividends paid
Sale and purchase of stock $0.84 $0.88 $95.56 $247.84
Net borrowings
Total cash flows from financing $0.84 $0.88 $95.56 $247.84
Effect of exchange rate $0.02 -$0.33 -$0.05 -$0.6
Change in cash and equivalents -$48.25 -$174.91 $8.03 $231.39
Fundamentals
Market cap $196.96M
Enterprise value $89.10M
Shares outstanding 42.18M
Revenue $51.13M
EBITDA -$99.03M
EBIT -$103.18M
Net Income -$93.80M
Revenue Q/Q -28.31%
Revenue Y/Y -61.21%
P/E ratio -2.10
EV/Sales 1.74
EV/EBITDA -0.90
EV/EBIT -0.86
P/S ratio 3.85
P/B ratio 0.93
Book/Share 5.03
Cash/Share 2.64
EPS -$2.22
ROA -31.84%
ROE -39.82%
Debt/Equity 0.20
Net debt/EBITDA 0.70
Current ratio 6.24
Quick ratio 6.24